Filtros de búsqueda

Lista de obras de

'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning

artículo científico publicado en 2003

4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement

scientific article published on 01 August 1996

4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery

artículo científico publicado en 1994

A Schematic Approach to Preexisting Sinus Disease for the Immunocompromised Individual ⬇️

artículo científico publicado el 1 de marzo de 1998

A dramatic story of hope and reality

artículo científico publicado en 2008

A phase 1 study of lucatumumab, a fully human anti‐CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma ⬇️

artículo científico publicado el 4 de agosto de 2012

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

artículo científico publicado en 2005

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

artículo científico publicado en 2014

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

artículo científico publicado en 2012

A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.

artículo científico publicado en 2008

A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

artículo científico publicado en 2009

A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma

artículo científico publicado el 1 de octubre de 1997

A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types

artículo científico publicado en 2014

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

artículo científico publicado en 2007

A predictive model for the detection of tumor lysis syndrome during AML induction therapy

artículo científico publicado en 2006

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490) ⬇️

artículo científico publicado el 15 de julio de 1995

Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition

artículo científico publicado en 2014

Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT.

artículo científico publicado en 2013

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

artículo científico publicado en 2003

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

artículo científico publicado en 2002

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

artículo científico publicado en 2001

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience

artículo científico publicado en 2013

Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study

artículo científico publicado en 2008

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration

artículo científico publicado en 2013

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

artículo científico publicado en 2019

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

artículo científico publicado en 2018

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

artículo científico publicado en 2002

Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection

artículo científico publicado en 2007

Association between mobilization regimen and PFS after auto-SCT for multiple myeloma.

artículo científico publicado en 2014

Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients ⬇️

artículo científico publicado el 14 de marzo de 2011

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.

artículo científico publicado en 2019

Autologous bone marrow transplant in acute myeloid leukemia in first remission

artículo científico publicado en 1993

Autologous bone marrow transplantation with in vitro chemotherapy purge in first remission of acute myeloid leukemia

artículo científico publicado el 1 de enero de 1992

Autologous bone marrow transplantation. A review of the principles and complications

artículo científico publicado en 1993

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial ⬇️

artículo científico publicado el 29 de septiembre de 2011

Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas

artículo científico publicado en 2016

Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy

artículo científico publicado en 1999

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

artículo científico publicado en 2019

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease ⬇️

artículo científico publicado el 12 de julio de 2012

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007

artículo científico publicado en 2007

Blood and marrow transplant clinical trials network state of the Science Symposium 2014

artículo científico publicado en 2014

Bone marrow purging with oligodeoxynucleotides

scientific article published on 01 August 1996

Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials

artículo científico publicado en 2006

Bortezomib in relapsed or refractory Waldenström's macroglobulinemia

scientific article published on March 2009

Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group

artículo científico publicado en 2007

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

artículo científico publicado en 2005

Bortezomib-induced tumor lysis syndrome in multiple myeloma

artículo científico publicado en 2006

Breast tumor cell contamination of hematopoietic stem cell collections

artículo científico publicado en 2001

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies.

artículo científico publicado en 2017

CRISPR-engineered T cells in patients with refractory cancer

scientific article published on 07 February 2020

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

scientific article published on 14 June 2013

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.

artículo científico publicado en 2015

Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

artículo científico publicado en 2017

Cellular and vaccine immunotherapy for multiple myeloma.

artículo científico publicado en 2016

Cellular immunotherapy for plasma cell myeloma.

artículo científico

Cerebral spinal fluid involvement by Hodgkin's disease diagnosed by CSF cytology and immunocytochemistry

artículo científico publicado en 1999

Changing Presentation and Management of Neutropenic Enterocolitis

artículo científico publicado en 1998

Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303 ⬇️

artículo científico publicado el 26 de agosto de 2011

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

artículo científico publicado en 2015

Chimeric Antigen Receptor T Cells in Myeloma

artículo científico publicado en 2016

Chronic lymphocytic leukemia: new concepts and emerging therapies

scientific article published on 24 January 2009

Classifying ultra-high risk smoldering myeloma.

artículo científico publicado en 2014

Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset

artículo científico publicado en 2020

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis

artículo científico publicado en 2012

Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells

artículo científico publicado en 2014

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

artículo científico publicado en 2010

Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

artículo científico publicado en 2014

Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder

artículo científico publicado en 1998

Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation

scientific article published on 29 August 2019

Concurrent administration of interferon alfa-2b and beta-1a

artículo científico publicado en 2003

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

artículo científico publicado en 2010

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

artículo científico publicado en 2015

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

artículo científico publicado en 2015

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

artículo científico publicado en 2000

Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer ⬇️

artículo científico publicado el 1 de diciembre de 1997

Danazol treatment of myelodysplastic syndromes ⬇️

artículo científico publicado el 1 de abril de 1991

Do simultaneous bilateral tunneled infusion catheters in patients undergoing bone marrow transplantation increase catheter-related complications?

artículo científico publicado en 2004

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2017

Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort

artículo científico publicado en 2005

EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial

artículo científico publicado en 2008

Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning

artículo científico publicado en 2014

Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490).

artículo científico publicado en 1999

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

artículo científico publicado en 2003

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial

artículo científico publicado en 2019

Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer

artículo científico publicado en 2001

Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients

scientific article published on 18 June 2020

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma

artículo científico publicado en 2011

Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone

article

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

artículo científico publicado en 2008

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

artículo científico publicado en 2001

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.

artículo científico publicado en 2006

Etoposide in leukemia, lymphoma and bone marrow transplantation

artículo científico publicado en 1989

Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene

artículo científico publicado en 2007

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma

artículo científico publicado en 2009

Extended CCR5 Blockade for Graft-Versus-Host Disease Prophylaxis Improves Outcomes of Reduced Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial

scientific article published on 10 October 2018

Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

scientific article published on 09 August 2007

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

artículo científico publicado en 1999

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

artículo científico publicado en 2005

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

artículo científico publicado en 2015

Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients

scientific article published on 24 November 2018

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation

artículo científico publicado en 2005

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

scientific article published on 01 July 2002

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

artículo científico publicado en 2002

Guidelines for prophylactic platelet transfusions: need for a concurrent outcomes management system

artículo científico publicado el 1 de diciembre de 1992

Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study

artículo científico publicado en 2016

Hematologic Malignancies: Plasma Cell Disorders

artículo científico

Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy

scientific article published on 19 February 2020

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

artículo científico publicado en 2015

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

artículo científico publicado en 2002

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials ⬇️

artículo científico publicado el 18 de julio de 2011

High-Throughput Sequencing of Antibody Genes Successfully Identifies Clonal Ig Rearrangements in Multiple Myeloma Patients

article

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol ⬇️

artículo científico publicado el 1 de abril de 1992

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed

artículo científico publicado en 2006

High-dose chemotherapy and stem cell support for breast cancer: where are we now?

artículo científico publicado en 2002

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

scientific article published on 01 May 1997

High-dose chemotherapy with autologous stem cell support for breast cancer.

artículo científico publicado en 1992

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT ⬇️

artículo científico publicado el 6 de febrero de 2012

High-dose cytarabine neurotoxicity: MR findings during the acute phase

artículo científico publicado en 1993

High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer

artículo científico publicado en 1994

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry

artículo científico publicado en 2002

Higher Donor Apheresis Blood Volumes are Associated with a Reduction in Relapse Risk and Improved Survival in Reduced Intensity Allogeneic Transplants with Unrelated Donors.

artículo científico publicado en 2018

Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemia

artículo científico publicado en 2002

Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation

artículo científico publicado en 2003

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

artículo científico publicado en 2013

Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee

artículo científico publicado en 2014

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

artículo científico publicado en 2008

Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma

artículo científico publicado en 2009

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

artículo científico publicado en 2006

Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902

scientific article published on 12 July 2020

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.

artículo científico publicado en 2010

Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment

artículo científico publicado en 2016

Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).

artículo científico publicado en 2005

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation

artículo científico publicado en 2005

Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer

artículo científico publicado en 2003

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

artículo científico publicado en 2020

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

Lenalidomide after stem-cell transplantation for multiple myeloma

artículo científico publicado en 2012

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

artículo científico publicado en 2009

Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2014

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

artículo científico publicado en 2007

Leukemic gingival infiltrate as an indicator of chemotherapeutic failure following monoclonal antibody therapy: a case report

artículo científico publicado en 2003

Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation

artículo científico publicado en 2017

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia

artículo científico publicado en 2020

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

scientific article published on 01 December 2005

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

artículo científico publicado en 2009

Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma

scientific article published on 01 July 2019

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation

scientific article published on 14 April 2020

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

artículo científico publicado el 12 de febrero de 2011

Medical management update: multiple myeloma.

artículo científico publicado en 2007

Melphalan desensitization following immediate hypersensitivity in a patient undergoing conditioning for autologous hematopoietic cell transplantation

artículo científico publicado en 2016

Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.

artículo científico publicado en 2014

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

artículo científico publicado en 2009

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

artículo científico publicado en 2006

Multiple myeloma, 2004--one or two transplants?

scientific article published on 01 December 2003

Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy

artículo científico publicado en 2013

NF-kappaB, IL-6 and myeloma cell growth: making the connection

scientific article published on 21 October 2004

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

artículo científico publicado en 2015

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

artículo científico publicado en 2002

Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients

artículo científico publicado en 2019

Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study

artículo científico publicado en 2002

Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

scientific article published on 29 May 2019

Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients

scientific article published on 01 May 2019

Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis

artículo científico publicado en 2017

Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era ⬇️

artículo científico publicado el 1 de agosto de 2013

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

artículo científico publicado en 2015

Peripheral blood progenitor cell generation and harvesting

artículo científico publicado en 1995

Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma

scientific article published on 01 October 1999

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

artículo científico publicado en 2015

Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer.

artículo científico publicado en 2000

Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma

artículo científico publicado en 2013

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells

artículo científico publicado en 1996

Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the

artículo científico publicado el 11 de marzo de 2013

Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation ⬇️

artículo científico publicado el 28 de abril de 2013

Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients

artículo científico publicado en 2013

Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report

artículo científico publicado en 2018

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

artículo científico publicado en 2009

Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs ⬇️

artículo científico publicado el 1 de enero de 2010

Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: resul

artículo científico publicado el 6 de junio de 2012

Poor-prognosis germ cell tumors: we have not yet crossed the finish line

artículo científico publicado en 2007

Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

artículo científico publicado en 2011

Post-transplant lymphoproliferative disorder: a review

artículo científico publicado en 2003

Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support

artículo científico publicado en 2007

Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases

scientific article published on 01 May 2007

Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance ⬇️

artículo científico publicado el 14 de noviembre de 2011

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR)

artículo científico publicado en 2010

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

scientific article published on 12 June 2006

Progressive Intermediate-Grade Non-Hodgkin's Lymphoma After High-Dose Therapy and Autologous Peripheral Stem-Cell Transplantation: Changing the Natural History with Monoclonal Antibody Therapy ⬇️

artículo científico publicado el 1 de junio de 2000

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

scientific article published on 12 June 2019

Proteasome inhibition for treatment of multiple myeloma: clinical update.

artículo científico publicado en 2004

Pupil-Involving Third Nerve Palsy as a Manifestation of Anti-Myelin–Associated Glycoprotein Neuropathy ⬇️

artículo científico publicado el 1 de marzo de 2011

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

artículo científico publicado en 2001

R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma

artículo científico publicado en 2014

Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?

artículo científico publicado en 2003

Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

scientific article published on 29 July 2016

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation ⬇️

artículo científico publicado el 8 de septiembre de 2010

Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.

artículo científico publicado en 2009

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

artículo científico publicado en 2009

Reactive lymphohistiocytosis with recurrence in the optic chiasm

artículo científico publicado en 1991

Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens ⬇️

artículo científico publicado el 5 de junio de 2013

Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG)

artículo científico publicado en 1994

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

artículo científico publicado en 2001

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★ ⬇️

artículo científico publicado el 10 de enero de 2011

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

artículo científico publicado en 2005

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline

artículo científico publicado en 2009

Risk of Invasive Fungal Infections in Patients with High-Risk MDS and AML Receiving Hypomethylating Agents

scientific article published on 03 April 2020

Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors

artículo científico publicado en 2016

Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

scientific article published on 01 September 1999

Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma

artículo científico publicado en 2007

Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation

artículo científico publicado en 2014

Safety and efficacy of upfront plerixafor + G‐CSF versus placebo + G‐CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non‐Hodgkin's lymphoma or multiple myeloma ⬇️

artículo científico publicado el 9 de septiembre de 2013

Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma

artículo científico publicado en 2008

Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder

artículo científico publicado en 2005

Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation

artículo científico publicado en 2000

Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen

artículo científico publicado en 2010

Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination

scientific article published on 01 December 1999

Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis

artículo científico publicado en 2008

Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

artículo científico publicado en 2019

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

scientific article published on 01 October 2019

Tailoring initial treatment for newly diagnosed, transplantation-eligible multiple myeloma.

artículo científico publicado en 2010

Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial

artículo científico publicado en 2019

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

artículo científico publicado en 2015

The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies

artículo científico publicado en 2016

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

artículo científico publicado en 2010

The evolving role of plerixafor in hematopoietic progenitor cell mobilization ⬇️

artículo científico publicado el 30 de enero de 2013

The presence of amyloid in abdominal and oral mucosal tissues in patients initially diagnosed with multiple myeloma: a pilot study

artículo científico publicado en 2011

The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma

artículo científico publicado en 2008

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

artículo científico publicado en 2004

Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.

artículo científico publicado en 2016

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract

artículo científico publicado en 2018

Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

artículo científico publicado en 2010

Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma ⬇️

artículo científico publicado el 30 de noviembre de 2010

Treatment of PTLD with rituximab or chemotherapy

artículo científico publicado en 2006

Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor

artículo científico publicado en 2000

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study ⬇️

artículo científico publicado el 14 de mayo de 2013

Trials with gemtuzumab ozogamicin (Mylotarg) combined with chemotherapy regimens in acute myeloid leukemia

artículo científico publicado en 2002

Trimming the fat: obesity and hematopoietic cell transplantation ⬇️

artículo científico publicado el 29 de octubre de 2012

Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality

artículo científico publicado en 2008

Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer

artículo científico publicado en 2001

Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation

artículo científico publicado en 2016

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2017

Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients

artículo científico publicado en 2002

Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.

artículo científico publicado en 2003

Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis

artículo científico publicado en 2007

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

artículo científico publicado en 2009

What Did We Learn in 2010 from the Phase III Trials? Is Maintenance Therapy the New Standard for Myeloma? ⬇️

artículo científico publicado el 1 de enero de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda